vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in vTv Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +4 vs. Q2 2022
- Shares held
- 3.49M
- −156.1K (−4.3%) vs. Q2 2022
- Total value
- $3.38M
- +$634.1K (+23.1%) vs. Q2 2022
- New holders
- 5
- 5 more added
- Sold out
- 1
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 500 | $0 | 0.00% | −100−16.7% | Reduced |
| Royal Bank of Canada | 173 | $0 | 0.00% | +44+34.1% | Added |
| Northwest Investment Counselors, LLC | 500 | $0 | 0.00% | +500 | New |
| BNP Paribas Arbitrage, SA | 330 | $320 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,060 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,211 | $2.00K | 0.00% | +1,009+83.9% | Added |
| Tower Research Capital LLC (TRC) | 4,577 | $4.00K | 0.00% | +4,577 | New |
| Focused Wealth Management, Inc | 5,000 | $5.00K | 0.00% | +5,000 | New |
| Strengthening Families & Communities, LLC | 7,142 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,760 | $13.0K | 0.00% | +13,760 | New |
| Veritable, L.P. | 20,905 | $20.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,233 | $22.0K | 0.00% | +1,555+7.5% | Added |
| Bridgeway Capital Management, LLC | 27,018 | $26.0K | 0.00% | +27,018 | New |
| Simon Quick Advisors, LLC | 30,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 32,385 | $31.0K | 0.00% | +14,590+82.0% | Added |
| Citadel Advisors LLC | 33,012 | $32.0K | 0.00% | −4,256−11.4% | Reduced |
| Morgan Stanley | 33,443 | $32.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 40,577 | $39.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 40,000 | $39.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 43,954 | $43.0K | 0.00% | +5,395+14.0% | Added |
| BlackRock Inc. | 55,420 | $54.0K | 0.00% | −287−0.5% | Reduced |
| Millennium Management LLC | 77,339 | $75.0K | 0.00% | −61,344−44.2% | Reduced |
| State Street Corp | 134,745 | $131.0K | 0.00% | −71,400−34.6% | Reduced |
| Geode Capital Management, LLC | 290,000 | $281.0K | 0.00% | −76,618−20.9% | Reduced |
| Vanguard Group Inc | 938,970 | $911.0K | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,635,509 | $1.59M | 0.37% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −15,590−100.0% | Sold out |